Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Biogen today and set a price target of $214.00. Matteis covers the Healthcare secto......

Wedbush analyst Laura Chico maintained a Hold rating on Biogen today and set a price target of $191.00. According to TipRanks, Chico is a 5-star an......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gossamer Bio (GOSS) and Biogen (BIIB). Gossamer Bio (GOSS) In a r......

Biogen ( ($BIIB) ) just unveiled an update. On March 31, 2026, Biogen signed a merger agreement to acquire Apellis Pharmaceuticals via a tender off......

The latest stock market stories for Tuesday are ready to go in the daily wrap-up. ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biogen (BIIB) and Kezar Life Sciences (KZR). Bioge......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definitive Healthcare Corp (DH) and Biogen (BIIB). Definitive Hea......

Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) has launched a Phase 3 trial called “A Phase 3 Study Wi......

Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) has completed a Phase 1 study titled “A Phase 1, Open-L......

Oppenheimer analyst Jay Olson maintained a Buy rating on Biogen today and set a price target of $250.00. According to TipRanks, Olson is a 5-star a......